ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Roswell Park Wins High Priority Score, Full Budget Recommendation For Core Grant.

January 11, 2008

Report Urges Heated Chemo To Optimize Patient Survival

November 24, 2006

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Rauscher Disappointed In CREG Progress

October 1, 1976

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

February 15, 1991